PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | |cirrhosis |
| Sentences | 171 |
| PubMedID- 21649567 | Conclusions: the incidence of hepatocellular carcinoma in patients with cirrhosis who have undergone a liver transplant at our hospital is similar to those reported in other studies. |
| PubMedID- 24965914 | Cumulative overall survival in hepatocellular carcinoma (hcc) patients with liver cirrhosis, tumor size within 3 cm and up to 3 nodules treated with radiofrequency ablation (rfa) (n = 179) and surgical resection (sr) (n = 179) after propensity score matching. |
| PubMedID- 25009403 | Conclusion: this review suggests that laparoscopic resection of hepatocellular carcinoma in patients with cirrhosis is safe and may provide improved patient outcomes when compared to the open technique. |
| PubMedID- 25335877 | Purpose: the aim of this study was to construct a prediction model for posthepatectomy liver failure (phlf), as defined by the international study group of liver surgery, and evaluate its accuracy in hepatocellular carcinoma (hcc) patients with cirrhosis or chronic hepatitis. |
| PubMedID- 24636295 | Objective: to investigate the role of absent ductular reaction (dr) at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma (hcc) with cirrhosis in patients with chronic hepatitis b. |
| PubMedID- 24940392 | The prevalence of cirrhosis in patients with hepatocellular carcinoma (ht) is between 80 and 90%, while 10–20% of ht cases develop in patients without cirrhosis (7). |
| PubMedID- 23756865 | hepatocellular carcinoma is associated with cirrhosis and hepatic dysfunction in 80% of patients, which makes its prognosis and treatment more difficult than in many other cancers (sengupta and siddiqi, 2012). |
| PubMedID- 20304209 | The best treatment for hepatocellular carcinoma (hcc) associated with liver cirrhosis is liver transplantation and the best results are obtained when the tumors fulfill the milan criteria. |
| PubMedID- 20857114 | Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma. |
| PubMedID- 25544499 | Infection with hepatitis c virus (hcv), a major viral cause of chronic liver disease, frequently progresses to steatosis and cirrhosis, which can lead to hepatocellular carcinoma. |
| PubMedID- 26431433 | Persistent infection with hbv can cause severe liver injury, cirrhosis, and the development of hepatocellular carcinoma (hcc) [1]. |
| PubMedID- 25961631 | Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis c virus. |
| PubMedID- 21286421 | A 49-year-old man (body weight: 86 kg, height: 169 cm) who was diagnosed as having hepatocellular carcinoma with liver cirrhosis due to hepatitis b virus (child-pugh grade c, meld score 14) presented for ldlt. |
| PubMedID- 24564496 | To demonstrate its utility, we applied rmani to a hepatocellular microarray dataset containing normal tissue and three disease conditions: pre-malignant (cirrhosis), cirrhosis with hepatocellular carcinoma (cirrhosishcc), and hepatocellular tumor (hcc). |
| PubMedID- 21318009 | Moreover, chronic alcohol consumption is an established risk factor for the development of hepatocellular carcinoma in patients with liver cirrhosis [110]. |
| PubMedID- 21991498 | A 67-year-old woman with compensated cirrhosis type b associated with hepatocellular carcinoma was started on sorafenib for multiple pulmonary metastases. |
| PubMedID- 22537432 | Most cases of hepatocellular carcinoma (hcc) are associated with cirrhosis related to chronic hepatitis b virus (hbv) or hepatitis c virus (hcv) infection. |
| PubMedID- 20578139 | Surveillance for hepatocellular carcinoma (hcc) in patients with cirrhosis is recommended but may not be performed. |
| PubMedID- 25091611 | hepatocellular carcinoma (hcc)-closely associated with liver cirrhosis and, in fact, the main cause of death in patients with such disease-is now recognized as one of the most-prevalent and lethal neoplasms worldwide. |
| PubMedID- 22792259 | hepatocellular carcinoma is frequently associated with advanced cirrhosis due to chronic hepatitis c. progressive liver damage until hcc development in chronic hcv-infected patients encompasses deregulation of molecular pathways triggering malignant transformation. |
| PubMedID- 22743730 | Case report: a 60 year-old man underwent ldlt for hepatitis c virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 23047000 | hepatocellular carcinoma in patients without cirrhosis in italy. |
| PubMedID- 22666283 | The aim of this paper was to evaluate host immunity in liver cirrhosis (lc) patients with advanced hepatocellular carcinoma (ahcc) receiving sorafenib therapy. |
| PubMedID- 25630422 | Laparoscopic radiofrequency ablation should be considered a safe treatment for hepatocellular carcinoma patients with severe cirrhosis and impaired icg-15 test. |
| PubMedID- 23372775 | In china, approximately 40 million people are infected with hcv [5], and it is estimated that 50% to 85% of all individuals infected with hcv develop chronic hepatitis; of these patients, 20% to 30% progress to liver cirrhosis that may lead to hepatocellular carcinoma (hcc). |
| PubMedID- 24157306 | Hepatitis c virus (hcv) is a global health problem, affecting approximately 170 million, and results in a chronic degenerative liver disease that is characterised by hepatic fibrosis, cirrhosis and in 10% of cases hepatocellular carcinoma. |
| PubMedID- 23769105 | Liver transplantation (lt) is a life-saving treatment for liver cirrhosis patients with hepatocellular carcinoma (hcc). |
| PubMedID- 25398070 | Risk of hepatocellular carcinoma also persists in patients with cirrhosis even if cure of hcv infection is achieved. |
| PubMedID- 21210013 | Aim: the ultrasonographic (us) detection of hepatocellular carcinoma (hcc) in patients with liver cirrhosis is based on the visualization of focal lesions. |
| PubMedID- 24760057 | Conclusions: considering the existence of alterations in the metabolism of nutrients in liver cirrhosis patients with and without hepatocellular carcinoma, and also that conventional nutritional assessment methods present limitations for this population, the biochemical laboratorial exams are valid to complement the diagnosis of the nutritional state in a quick and practical manner. |
| PubMedID- 26404355 | The second option is to achieve on treatment undetectable hcv rna at lt. in a recent study, aimed to prevent hcv recurrence on the graft, sof plus rbv was used in 61 lt candidates (genotype 1: 74%, previously treated: 75%, median model for end-stage liver disease (meld) score = 8; 6 to 14) listed for compensated cirrhosis with hepatocellular carcinoma, until the time of lt or for up to 48 weeks [37]. |
| PubMedID- 20969743 | As of january, 2010, after a median follow-up of 16.7 months (iqr: 11.3-25.3), 13 new cases of decompensated cirrhosis, nine hepatocellular carcinomas and 20 hcv-related deaths were reported, resulting in a cumulative hcv-related severe event rate of 1.9/100 person-years (95% ci: 1.3-2.5). |
| PubMedID- 21388559 | In 40-60% of hcv-infected individuals, persistent infection is mainly associated with liver cirrhosis and steatosis, leading to hepatocellular carcinoma (hcc) [2,3]. |
| PubMedID- 25459558 | Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants. |
| PubMedID- 24627603 | A total of 270 patients with hepatocellular carcinoma complicated by cirrhosis were included in the study. |
| PubMedID- 20517910 | All the patients had hepatitis b virus-related cirrhosis with hepatocellular carcinoma. |
| PubMedID- 22226387 | [results of percutaneous radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis aged 75 years and over]. |
| PubMedID- 22099524 | Aim: to assess whether t2-weighted imaging (t2wi) provides any added value for the detection of hepatocellular carcinoma (hcc) in patients with cirrhosis, especially for lesions smaller than 2 cm. |
| PubMedID- 22686857 | Guidelines on nutritional management in japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma. |
| PubMedID- 24559750 | Mri of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (cirrhosis and chronic viral hepatitis: a comparative study. |
| PubMedID- 21389798 | Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. |
| PubMedID- 25725223 | Chronic hepatitis b virus (chb) infection can cause persistent hepatic inflammation and cirrhosis, which may lead to hepatocellular carcinoma (hcc). |
| PubMedID- 22232996 | [accuracy of multislice computed tomography in the diagnosis of hepatocellular carcinoma in patients with cirrhosis evaluated for liver transplantation]. |
| PubMedID- 23826593 | cirrhosis may be complicated by hepatocellular carcinoma or liver failure. |
| PubMedID- 25841913 | Management of liver cirrhosis in patients with hepatocellular carcinoma. |
| PubMedID- 25891119 | The present study examined the prognostic ability of our proposed performance status combined japan integrated staging (ps-jis) system in hepatocellular carcinoma (hcc) patients with liver cirrhosis (lc) comparing with other four prognostic systems including original jis system, the barcelona clinic liver cancer classification system, tnm classification system and the cancer of the liver italian program (clip) scoring system. |
| PubMedID- 24020023 | Indications for living-donor liver transplantation in these patients were hepatitis b cirrhosis with hepatocellular carcinoma (n = 8), hepatitis b cirrhosis without hepatocellular carcinoma (n = 3), autoimmune disease (n = 1), and wilson's disease (n = 2). |
| PubMedID- 24919730 | Liver transplant is the preferred treatment for hepatocellular carcinoma in patients with cirrhosis, as both neoplastic and cirrhotic liver tissue can be removed. |
| PubMedID- 22902757 | Background & aims: we aimed to identify risk factors for hepatocellular carcinoma (hcc) in patients with cirrhosis in the united states. |
| PubMedID- 20505515 | Metabolic risk factors are a major comorbidity in patients with cirrhosis independent of the presence of hepatocellular carcinoma. |